Comprehensive risk analysis of postoperative complications in patients with rheumatoid arthritis for the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis.


Journal

Modern rheumatology
ISSN: 1439-7609
Titre abrégé: Mod Rheumatol
Pays: England
ID NLM: 100959226

Informations de publication

Date de publication:
28 Feb 2022
Historique:
received: 15 01 2021
accepted: 01 04 2019
pubmed: 16 4 2021
medline: 3 6 2022
entrez: 15 4 2021
Statut: ppublish

Résumé

To examine the risk factors of surgical site infection (SSI), delayed wound healing, and death after orthopedic surgery in patients with rheumatoid arthritis (RA). We identified articles indexed in the Cochrane Library, PubMed, and Japan Centra Revuo Medicina Web published from 2013 to 2019 and other articles. Articles fulfilling the predefined inclusion criteria were reviewed systematically and their quality was appraised according to the Grading of Recommendations Assessment, Development, and Evaluation system with some modifications. After inclusion and exclusion by full-text review, 29 articles were analyzed. Use of biological disease modifying antirheumatic drugs was a risk factor of SSI (risk ratio 1.66, 95% confidence interval 1.25-2.19), but not of delayed wound healing. RA itself was a risk factor of SSI, and oral glucocorticoid use was a risk factor of SSI in three of the four studies analyzed and of postoperative death. Age, male sex, comorbidities such as diabetes mellitus and chronic obstructive pulmonary disease, surgical factors such as foot/ankle and spine surgery and longer operative time were risk factors of those postoperative complications. Patients with those factors should be dealt with appropriate cautions to strike a risk-benefit balance of orthopedic surgeries.

Identifiants

pubmed: 33855932
doi: 10.1080/14397595.2021.1913824
pii: 6470734
doi:

Substances chimiques

Antirheumatic Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

296-306

Informations de copyright

© 2021 Japan College of Rheumatology.

Auteurs

Hiromu Ito (H)

Department of Advanced Medicine for Rheumatic Diseases and Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Koichi Murata (K)

Department of Advanced Medicine for Rheumatic Diseases and Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Yasumori Sobue (Y)

Department of Orthopedic Surgery, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya, Japan.
Department of Orthopedic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Toshihisa Kojima (T)

Department of Orthopedic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Keiichiro Nishida (K)

Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Density and Pharmaceutical Sciences, Okayama, Japan.

Isao Matsushita (I)

Department of Rehabilitation Medicine, Kanazawa Medical University, Ishikawa, Japan.

Yutaka Kawahito (Y)

Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Masayo Kojima (M)

Center for Gerontology and Social Science, National Center for Geriatrics and Gerontology, Aichi, Japan.

Shintaro Hirata (S)

Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.

Yuko Kaneko (Y)

Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.

Mitsumasa Kishimoto (M)

Department of Nephrology and Rheumatology, Kyorin University School of Medicine, Tokyo, Japan.

Masataka Kohno (M)

Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Masaaki Mori (M)

Department of Lifetime Clinical Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Akio Morinobu (A)

Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan.

Atsuko Murashima (A)

Center for Maternal-Fetal, Neonatal and Reproductive Medicine/Japan Drug Information Institute in Pregnancy, National Center for Child Health and Development, Tokyo, Japan.

Yohei Seto (Y)

Department of Rheumatology, Yachiyo Medical Center, Tokyo Women's Medical University, Chiba, Japan.

Takahiko Sugihara (T)

Department of Lifetime Clinical Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University.

Eiichi Tanaka (E)

Department of Rheumatology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.

Takeo Nakayama (T)

Department of Health Informatics, Kyoto University School of Public Health, Kyoto, Japan.

Masayoshi Harigai (M)

Department of Rheumatology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH